IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2014 Holdings

Filed 2014-11-14 | 14 holdings | $258.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ariad Pharmaceuticals IncCOM04033A100$69.4K12,850,00026.8%
Quest Diagnostics Inc(DGX)COM74834L100$47.0K775,00018.2%
Bio-Reference Labs IncCOM $.01 NEW09057G602$35.9K1,280,98413.9%
Agilent Technologies Inc.(A)COM00846U101$26.2K460,00010.1%
Merck & Co Inc New(MRK)COM58933Y105$23.7K400,0009.2%
Amgen Inc(AMGN)COM031162100$16.9K120,0006.5%
Repros Therapeutics IncCOM NEW76028H209$11.2K1,132,3674.3%
Vivus IncCOM928551100$9.9K2,573,9433.8%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$4.9K360,0001.9%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$4.2K105,0001.6%
Kindred Biosciences IncCOM494577109$3.6K390,0001.4%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.9K2,570,7591.1%
Targacept IncCOM87611R306$1.6K630,0000.6%
Onconova Therapeutics IncCOM68232V108$1.5K350,0000.6%